AMA has not withdrawn support for ABA services after all

NewsNorth AmericaAMA has not withdrawn support for ABA services after all

Comes after ICDL leader spoken out his thoughts on the developments at AMA’s conference

The American Medical Association (AMA) did not withdraw support for ABA therapy to be used on autistic individuals.

In recent weeks, speculation surrounding the AMA’s continued stance surrounding ABA has garnered attention, with Jeff Guenzel, Leader of ICDL and DIR Floortime even speaking out about the developments.

Advertisement

But AU-TI has seen the full document from the AMA’s general meeting and in particular draft resolution 706, which advocated for the removal of support for ABA therapy to be used on autistic individuals.

The proposal originated from the Medical Student Section (MSS) of the AMA who vehemently oppose ABA.

Advertisement

It was deliberated on by 704 delegates appointed by more than 190 state and speciality medical societies as their official representatives on the policy-making body of the AMA House of Delegates.

The process begins with the chance for delegates to offer testimony to the reference committee, who are responsible for evaluating all resolutions before they are voted on.

Resolution 706 was described as mixed with speakers from the HOD expressing support for expanding the AMA’s support of treatment for autistic individuals to be more inclusive of practices beyond ABA.

Some of the testimony discussed included the harm that autistic individuals have received from negative outcomes but also elaborated on the complexity of treating autistic people.

Advertisement

There was a consensus of the HOD that treatment and services has evolved over the years and that current practices have improved but some acknowledged the implications of an evolving ABA.

Some delegates suggested referral of resolution 706 while others offered amendments, with the AMA’s referencing committee issuing a recommendation to adopt an amended version.

The House of Delegates considered the recommendation during final deliberations before agreeing to support research toward the evaluation and development of interventions and programs for autistic people.

Text from the AMA conference regarding changes made to resolution 706

They also adopted to work with relevant stakeholders to advocate for a more comprehensive package of care that recognises the diversity of neurodivergent individuals.

"RESOLVED, That our American Medical Association support research toward the evaluation and the development of interventions and programs for autistic individuals. "

"RESOLVED, That our AMA work with relevant stakeholders to advocate for a comprehensive spectrum of primary and specialty care that recognizes the diversity and personhood of individuals who are neurodivergent, including people with autism."

The fully adopted resolutions by the AMA’s House of Delegates

The House of Delegates vote for a policy change means a broadening of the AMA’s stance on care towards autistic people. Instead of explicit support for ABA alone, the support is for autism services more generally.

While this means the new framework opens doors for alternative care and therapies like DIR Floortime, it does not rule out ABA continuing to be used.

"Testimony on resolution 706 was mixed. Speakers expressing support for the resolution spoke on the importance of expanding the AMA’s support of treatment for Autism Spectrum Disorder (ASD) to be inclusive of practices beyond Applied Behavior Therapy (ABA). Testimony also discussed the harm that some autistic individuals who have received ABA report negative outcomes, while others have not. The testimony also discussed the complexity of ASD and its treatments. Speakers discussed that ABA has evolved in practice since its initial implementation and that current practices have improved. Additionally, speakers acknowledged the evidence on the potential negative implications of ABA is still evolving. Some speakers suggested referral of this resolution while others offered amendments to the third resolve. To fully acknowledge the complex and ever-evolving field of ASD and its therapies, it is important to support research as indicated in the first resolve clause."

The official description on of the testimony heard by the reference committee on resolution 706

To the ABA industry this change could be seen as a signal for a more comprehensive approach who welcome evidence-based services which includes ABA.

However, it wil be seen as some what of a disappointment to some members of the autistic community who have been advocating for a full ban on ABA.

The leader of the ICDL, Jeff Guenzel, was more upbeat writing a comment for AU-TI, “The explicit focus on Applied Behavioral Analysis was withdrawn for the policy.

“Of course I would expect the ABA industry to rebuttal with the fact that ‘evidence-based services’ does not exclude ABA which it currently does not, but at the same time reviewing it from that narrow lens does not tell the [whole] story.”

Guenzel concluded by saying that a good part of debating the resolution process was rooted in valid concerns about ABA, including questions about the reported evidence-base services.

Jeff Guenzel has already spoken about the events at the AMA conference which he feels is ‘moving in the right direction.’

Advertisement

Check out our other content

Most Popular Articles